-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Intestinal lesions in Crohn's disease (CD) patients can easily develop into narrow or penetrating lesions.
This study shows that the use of immunosuppressants and tumor necrosis factor antagonists to treat asymptomatic endoscopic CD recurrence patients does not reduce the long-term clinical recurrence risk of patients with Rutgeerts score i2, but drug treatment for patients with i3 or i4 Can significantly reduce the risk of postoperative recurrence.
Original source:
Pauline Rivière.